Innoviva
INVA
143 hedge funds and large institutions have $4.28B invested in Innoviva in 2013 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 47 reducing their positions, and 24 closing their positions.
142% more call options, than puts
Call options by funds: $28.7M | Put options by funds: $11.9M
38% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 47
12% more capital invested
Capital invested by funds: $3.82B → $4.28B (+$455M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
5% less funds holding
Funds holding: 150 → 143 (-7)
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$135M |
| 2 |
BG
Baupost Group
Boston,
Massachusetts
|
+$76.1M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$36.5M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.2M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$18.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$174M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$47.2M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$15.1M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$14.8M |
| 5 |
ZDA
Zweig-DiMenna Associates
New York
|
-$10.2M |
INVA Hedge Fund Activity: Q3 2013 in Review
143 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q3 2013, worth a combined $4.28B — up 12% from $3.82B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of INVA and 20 opened new positions — a net loss of 4 holders — while 47 trimmed existing stakes and 65 added.
The largest buyer was OppenheimerFunds, adding an estimated $135M. The largest seller was T. Rowe Price Associates, cutting an estimated $174M.
- 143 institutional investors held Innoviva (INVA) as of Q3 2013, down from 150 in Q2 2013.
- Funds reported $4.28B of Innoviva stock for Q3 2013, up 12% quarter-over-quarter.
- 20 funds opened new Innoviva positions in Q3 2013 and 24 closed out, a net change of -4 holders.
- The largest Innoviva buyer in Q3 2013 was OppenheimerFunds, an estimated $135M added.
- The largest Innoviva seller in Q3 2013 was T. Rowe Price Associates, an estimated $174M sold.
Based on aggregated 13F filings for Q3 2013.